Search

everythinglearnresearchcommunity

for

Search:↓

Lipids from Schizochytrium sp. help prevent hair loss by protecting hair cells from damage and promoting hair growth.

A new method using nanolipogels with fucosterol can help regrow hair by targeting follicles, reducing inflammation, and improving blood flow.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

Topical tofacitinib is effective and safe for treating alopecia areata.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Mixing calcipotriol with a steroid is almost as effective as using a steroid alone for alopecia areata and has fewer side effects.

Oral JAK inhibitors effectively treat alopecia areata and are generally well-tolerated.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Baricitinib significantly improved hair regrowth and quality of life in severe alopecia areata patients.

Combining DPCP with PRP doesn't improve hair regrowth in alopecia areata.

Certain patient traits can predict better hair regrowth with baricitinib in severe alopecia areata.

Ritlecitinib and brepocitinib effectively regrow hair in alopecia areata patients.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Alopecia areata patients have lower vitamin D levels than healthy individuals.

The document concludes that using a person's own fat cells (SVF) can significantly increase hair thickness and density, suggesting it could be a promising treatment for hair loss.

Baricitinib helped regrow hair in patients with severe alopecia areata after other treatments failed.

Tamsulosin with Serenoa repens is as effective as with 5-alpha-reductase inhibitors but causes fewer side effects.

PRP treatment may help with alopecia areata, especially in newer cases.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

JAK inhibitors can help treat alopecia areata but have risks and high costs.

Baricitinib significantly improves nail and hair symptoms in severe alopecia areata.